|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Michaelson JS, Silverstein M, Wyatt J,
Weber G, Moore R, Halpern E, Kopans DB and Hughes K: Predicting the
survival of patients with breast carcinoma using tumor size.
Cancer. 95:713–723. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rakha EA, El-Sayed ME, Menon S, Green AR,
Lee AH and Ellis IO: Histologic grading is an independent
prognostic factor in invasive lobular carcinoma of the breast.
Breast Cancer Res Treat. 111:121–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shokouh TZ, Ezatollah A and Barand P:
Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status
and their associations with tumor grade and lymph node involvement
in breast carcinoma subtypes: Retrospective-observational
analytical study. Medicine (Baltimore). 94:e13592015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma J, Luo DX, Huang C, Shen Y, Bu Y,
Markwell S, Gao J, Liu J, Zu X, Cao Z, et al: AKR1B10
overexpression in breast cancer: Association with tumor size, lymph
node metastasis and patient survival and its potential as a novel
serum marker. Int J Cancer. 131:E862–E871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Crabb SJ, Bajdik CD, Leung S, Speers CH,
Kennecke H, Huntsman DG and Gelmon KA: Can clinically relevant
prognostic subsets of breast cancer patients with four or more
involved axillary lymph nodes be identified through
immunohistochemical biomarkers? A tissue microarray feasibility
study. Breast Cancer Res. 10:R62008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
M Braden A, V Stankowski R, M Engel J and
A Onitilo A: Breast cancer biomarkers: Risk assessment, diagnosis,
prognosis, prediction of treatment efficacy and toxicity, and
recurrence. Curr Pharm Des. 20:4879–4898. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nagini S: Breast Cancer: Current molecular
therapeutic targets and new players. Anticancer Agents Med Chem.
17:152–163. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
ENCODE Project Consortium, ; Birney E,
Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH,
Weng Z, Snyder M, Dermitzakis ET, et al: Identification and
analysis of functional elements in 1% of the human genome by the
ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clark MB, Johnston RL, Inostroza-Ponta M,
Fox AH, Fortini E, Moscato P, Dinger ME and Mattick JS: Genome-wide
analysis of long noncoding RNA stability. Genome Res. 22:885–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoon JH, Abdelmohsen K, Srikantan S, Yang
X, Martindale JL, De S, Huarte M, Zhan M, Becker KG and Gorospe M:
LincRNA-p21 suppresses target mRNA translation. Mol Cell.
47:648–655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gutschner T, Hammerle M and Diederichs S:
MALAT1-a paradigm for long noncoding RNA function in cancer. J Mol
Med (Berl). 91:791–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Turashvili G, Bouchal J, Baumforth K, Wei
W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J,
Srovnal J, et al: Novel markers for differentiation of lobular and
ductal invasive breast carcinomas by laser microdissection and
microarray analysis. BMC Cancer. 7:552007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hortobagyi GN, Edge SB and Giuliano A: New
and Important Changes in the TNM staging system for breast cancer.
Am Soc Clin Oncol Educ Book. 38:457–467. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen
X, Zhang Q, Yan G and Cui Q: LncRNA Disease: A database for
long-non-coding RNA-associated diseases. Nucleic Acids Res.
41((Database Issue)): D983–D986. 2013.PubMed/NCBI
|
|
24
|
Zou AE, Ku J, Honda TK, Yu V, Kuo SZ,
Zheng H, Xuan Y, Saad MA, Hinton A, Brumund KT, et al:
Transcriptome sequencing uncovers novel long noncoding and small
nucleolar RNAs dysregulated in head and neck squamous cell
carcinoma. RNA. 21:1122–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ylipää A, Kivinummi K, Kohvakka A, Annala
M, Latonen L, Scaravilli M, Kartasalo K, Leppänen SP, Karakurt S,
Seppälä J, et al: Transcriptome sequencing reveals PCAT5 as a novel
ERG-regulated long noncoding RNA in prostate cancer. Cancer Res.
75:4026–4031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song CV, Teo SH, Taib NA and Yip CH:
Surgery for BRCA, TP53 and PALB2: A literature review.
Ecancermedicalscience. 12:8632018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sundara Rajan S, Hanby AM, Horgan K,
Thygesen HH and Speirs V: The potential utility of geminin as a
predictive biomarker in breast cancer. Breast Cancer Res Treat.
143:91–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sørensen KP, Thomassen M, Tan Q, Bak M,
Cold S, Burton M, Larsen MJ and Kruse TA: Long non-coding RNA
HOTAIR is an independent prognostic marker of metastasis in
estrogen receptor-positive primary breast cancer. Breast Cancer Res
Treat. 142:529–536. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang YF, Liao YY, Yang M, Peng NF, Xie SR
and Xie YF: Discordances in ER, PR and HER2 receptors between
primary and recurrent/metastatic lesions and their impact on
survival in breast cancer patients. Med Oncol. 31:2142014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Coupland KG, Kim WS, Halliday GM, Hallupp
M, Dobson-Stone C and Kwok JB: Role of the long non-coding RNA
MAPT-AS1 in regulation of microtubule associated protein tau (MAPT)
expression in Parkinson's disease. PLoS One. 11:e01579242016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bradner JE, Hnisz D and Young RA:
Transcriptional Addiction in Cancer. Cell. 168:629–643. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Valcarcel-Jimenez L, Gaude E, Torrano V,
Frezza C and Carracedo A: Mitochondrial Metabolism: Yin and yang
for tumor progression. Trends Endocrinol Metab. 28:748–757. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Aithal MG and Rajeswari N: Role of Notch
signalling pathway in cancer and its association with DNA
methylation. J Genet. 92:667–675. 2013. View Article : Google Scholar : PubMed/NCBI
|
